UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of Earliest Event Reported): November
14, 2011
Express Scripts, Inc.
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Delaware
|
|
0-20199
|
|
43-1420563 |
|
|
|
|
|
(State or other jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
(I.R.S. Employer
Identification No.) |
|
|
|
One Express Way, St. Louis, MO
|
|
63121 |
|
|
|
(Address of principal
executive offices)
|
|
(Zip Code) |
Registrants telephone number, including area code 314-996-0900
Not Applicable
Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
TABLE OF CONTENTS
|
|
|
Item 7.01 |
|
Regulation FD Disclosure |
On
November 14, 2011, Express Scripts, Inc. (Express Scripts) issued a press release announcing
the commencement of a proposed financing transaction. The press release is attached hereto as Exhibit 99.1
and is incorporated herein by reference.
In connection with the proposed financing transaction, Express Scripts provided potential investors with unaudited pro
forma condensed combined financial information as of and for the nine months ended September 30,
2011 and for the year ended December 31, 2010. The unaudited pro forma condensed combined
financial information is derived from the historical financial statements of Express Scripts and
Medco Health Solutions, Inc. (Medco), adjusted to give effect to the proposed merger pursuant to
which Express Scripts and Medco will each become wholly owned
subsidiaries of Aristotle Holding, Inc. and certain
related financing transactions. The pro forma adjustments are preliminary and have been made
solely for informational purposes. As a result, the pro forma information is not intended to
represent and does not purport to be indicative of what the combined companys financial condition or
results of operations would have been had the merger or the related financing transactions occurred
at an earlier date. In addition, the pro forma financial information does not purport to project
the future financial condition and results of operations of the combined company. The actual
results of the combined company may differ significantly from those reflected in the pro forma
financial information. The unaudited pro forma condensed combined financial information is
attached hereto as Exhibit 99.2 and is incorporated herein by reference.
This information is furnished pursuant to Item 7.01 of Form 8-K and shall not be deemed filed for
purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange Act), or
otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by
reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except
as shall be expressly set forth by specific reference in such filing.
|
|
|
Item 9.01. |
|
Financial Statements and Exhibits. |
|
|
|
Exhibit No. |
|
Description |
99.1
|
|
Press Release, dated November 14, 2011. |
|
|
|
99.2
|
|
Unaudited Pro Forma Condensed Combined Financial Information as of and for the Nine
Months Ended September 30, 2011 and for the Year Ended December 31, 2010. |
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused
this report to be signed on its behalf by the undersigned, hereunto duly authorized.
|
|
|
|
|
|
Express Scripts, Inc.
(Registrant)
|
|
|
By: |
/s/ Keith Ebling
|
|
|
|
Name: |
Keith Ebling |
|
|
|
Title: |
Executive Vice President and General Counsel |
|
|
Dated:
November 14, 2011
3